- Filed
- Apr 28, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 16, 2026 | 145.43M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 146.6M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 148.8M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $25.1M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $100.5M |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $17.5M |
| Dividends Paid restated | Q1 2026 · Mar 31, 2025 | $17.9M |
| Capex | Q1 2026 · Mar 31, 2026 | $17.9M |
| Capex restated | Q1 2026 · Mar 31, 2025 | $32.6M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $122.5M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | $119.2M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $2.83B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $2.83B |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $635.1M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $573M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $2.86B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $2.79B |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | $2.85B |
| Stockholders Equity restated | Q1 2026 · Dec 31, 2024 | $2.89B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $758.6M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $775.1M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $3.96B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $3.97B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $2.09B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $1.99B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $6.82B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $6.75B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.59 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.47 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.60 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.47 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $93.4M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $86M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $31.9M |
| Rd Expense restated | Q1 2026 · Mar 31, 2025 | $36.8M |
| Net Income | Q1 2026 · Mar 31, 2026 | $87.1M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | $69.9M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $141.6M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | $122.2M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $648.5M |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $638.7M |
| Revenue | Q1 2026 · Mar 31, 2026 | $934.8M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $911.3M |